Monoclonal Mouse anti‑Human DAXX Antibody (Biotin, IHC, WB) LS‑C525449
Monoclonal Mouse anti‑Human DAXX Antibody (Biotin, IHC, WB) LS‑C525449
Antibody:
DAXX Mouse anti-Human Monoclonal (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
DAXX Mouse anti-Human Monoclonal (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
DAXX antibody LS-C525449 is a biotin-conjugated mouse monoclonal antibody to human DAXX. Validated for IHC and WB.
Target
Human DAXX
Synonyms
DAXX | BING2 | CENP-C binding protein | DAP6 | Death-associated protein 6 | EAP1 | Fas-binding protein | HDaxx | ETS1-associated protein 1
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
HRP,
PE.
Purification
Protein A purified
Immunogen
Recombinant C-Terminus DAXX protein (aa 558-740).
Specificity
Recognizes the apoptosis related protein DAXX.
Applications
- IHC
- Western blot
- Applications tested for the base form of this product only
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Immunofluorescence, Western blot, Flow Cytometry, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Species:
Human, Monkey
Applications:
IHC, IHC - Paraffin, ICC, Immunofluorescence, Western blot, Immunoprecipitation
Species:
Human
Applications:
Immunofluorescence, Western blot, ELISA
Reactivity:
Human
Range:
Positive/Negative
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 5/21/2024